Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for secondary Raynaud's syndrome
2004-002686-21Phase 3Completed
- Sponsor
- Department of Dermatology
- Start
- Jan 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bosentan in Raynaud disease, sponsored by Department of Dermatology. Primary endpoint: Raynaud's symptom score. Started Jan 2005; status: completed.
02
Drugs
bosentan
03
Conditions
Raynaud disease
Beyond the preview
Go deeper on 2004-002686-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002686-21.